LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER Drug Patent Profile

When do Lidocaine Hydrochloride Preservative Free In Plastic Container patents expire, and when can generic versions of Lidocaine Hydrochloride Preservative Free In Plastic Container launch?

Lidocaine Hydrochloride Preservative Free In Plastic Container is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-six suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Lidocaine Hydrochloride Preservative Free In Plastic Container

A generic version of LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER was approved as lidocaine hydrochloride by PHARMOBEDIENT on November 18^th, 1982.

Summary for LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	6
Raw Ingredient (Bulk) Api Vendors:	1
Clinical Trials:	19
Patent Applications:	4,314
DailyMed Link:	LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER at DailyMed

Recent Clinical Trials for LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Ain Shams University	NA
University of California, San Francisco	Phase 4
Sindh Institute of Urology and Transplantation	Phase 4

See all LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER clinical trials

Pharmacology for LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER

Drug Class	Amide Local Anesthetic Antiarrhythmic
Physiological Effect	Local Anesthesia

US Patents and Regulatory Information for LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hospira	LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER	lidocaine hydrochloride	INJECTABLE;INJECTION	040302-001	Sep 28, 1998	AP	RX	No	No
Hospira	LIDOCAINE HYDROCHLORIDE PRESERVATIVE FREE IN PLASTIC CONTAINER	lidocaine hydrochloride	INJECTABLE;INJECTION	040302-002	Sep 28, 1998	AP	RX	No	No

Market Dynamics and Financial Trajectory for Preservative-Free Lidocaine Hydrochloride in Plastic Containers

Last updated: March 18, 2026

What Are the Key Market Drivers?

The market for preservative-free lidocaine hydrochloride in plastic containers is influenced by several factors:

• Increasing demand for preservative-free formulations: Patients and healthcare providers prefer preservative-free drugs to minimize allergic reactions and other adverse effects. This demand is driven by a rising awareness of preservative-related sensitivities.
• Regulatory shifts: Agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) encourage preservative-free formulations to improve safety profiles.
• Growth of outpatient procedures: The rise in minor surgical procedures, dermatological treatments, and local anesthetic applications elevates the need for portable, easy-to-use formulations.
• Advancements in container technology: Innovations in plastic container manufacturing improve drug stability and shelf life, supporting market expansion.
• Competitive landscape dynamics: Major pharmaceutical companies are investing in preservative-free formulations to differentiate their product portfolios.

How Does Market Size and Growth Look?

The global local anesthetic market, which includes lidocaine products, is expected to grow at a compounded annual growth rate (CAGR) of approximately 4.2% between 2022 and 2028, reaching an estimated valuation of $3.2 billion in 2028 [1].

Within this segment, preservative-free lidocaine hydrochloride in plastic containers accounts for approximately 15–20% of the total local anesthetic market, with an annual growth rate projected between 4.5% and 6% over the next five years [2].

Market Segmentation Snapshot

Segment	Market Share (2022)	CAGR (2022-2028)	Comments
Preservative-free lidocaine	15–20%	4.5–6%	Driven by safety concerns and regulatory guidelines
Multi-dose preserved lidocaine	80–85%	2–3%	Lower growth rate due to preservative concerns

What Are the Competitive Factors?

Major players include AstraZeneca, Pfizer, and Teva Pharmaceuticals, which offer proprietary preservative-free formulations in plastic-tube or vial formats. Key competitive factors encompass:

• Formulation stability: Ensuring chemical integrity over shelf life.
• Container design: Using high-quality plastics such as polypropylene to prevent drug absorption and leaching.
• Regulatory compliance: Adherence to pharmacopeial standards for preservative-free products.
• Pricing strategies: Competitive pricing for hospitals, clinics, and outpatient settings.

Projected Revenue and Cost Trends

The average selling price (ASP) of preservative-free lidocaine in plastic containers varies between $3 to $7 per 10mL vial, depending on region and brand.

• Revenue estimation: For a mid-sized pharmaceutical company selling 1 million units annually at $5 per unit, gross revenue reaches $5 million.
• Cost considerations: Development costs range from $1 million to $2 million for formulation optimization, stability testing, and regulatory submission. Production costs, including raw materials and manufacturing, are approximately $1 per unit. Distribution and marketing costs add further to expenses.

Financial Trajectory

Year	Units Sold	Total Revenue	Production Cost	Gross Profit
2023	1 million	$5 million	$1 million	$4 million
2024	1.2 million	$6 million	$1.2 million	$4.8 million
2025	1.4 million	$7 million	$1.4 million	$5.6 million

Projected revenues grow as the market expands, driven by increased adoption and new product launches.

Regulatory and Supply Chain Considerations

• Regulatory pathways: Simplified under existing injectable drug guidelines; however, preservative-free claims may require additional stability data.
• Supply chain risks: Raw material availability (e.g., high-quality plastics) and manufacturing capacity could impact product launch timelines.
• Intellectual property: Patents on container design and formulation may influence market exclusivity.

Key Challenges

• Supply chain disruptions affecting raw materials.
• Competition from multi-dose preservative-containing products.
• Cost pressures from healthcare systems favoring lower-priced options.

Strategic Opportunities

• Developing multi-use, preservative-free containers with improved sealing technology.
• Licensing agreements to expand distribution in emerging markets.
• Integrating with broader pain management and local anesthetic portfolios.

Key Takeaways

The market for preservative-free lidocaine hydrochloride in plastic containers is expanding amid safety concerns and regulatory support. Financial prospects are favorable, with steady growth driven by increased outpatient procedures and container innovations. Competitive success depends on formulation stability, regulatory adherence, and supply chain management.

FAQs

1. What drives the demand for preservative-free lidocaine?
   Safety concerns, regulatory encouragement, and patient preferences favor preservative-free formulations.

2. What is the expected CAGR for this market segment?
   Between 4.5% and 6% from 2022 to 2028.

3. Which regions show the greatest growth potential?
   North America and Europe lead, with Asia-Pacific experiencing rapid expansion due to healthcare infrastructure developments.

4. What pricing strategies are typical for preservative-free lidocaine?
   Between $3 and $7 per 10mL vial, depending on the market and distribution channel.

5. What are the main regulatory hurdles?
   Demonstrating stability and safety in preservative-free formulations; compliance with pharmacopeial standards.

---

References

[1] MarketsandMarkets. (2022). Local Anesthetics Market by Type, Application, and Region.
[2] Grand View Research. (2023). Global Local Anesthetics Market Size, Share & Trends.